Skip to main content
Log in

Pentoxifylline, total urinary protein excretion rate and arterial blood pressure in long-term insulin-dependent diabetic patients with overt nephropathy

  • Original Contributions
  • Published:
Acta diabetologia latina Aims and scope Submit manuscript

Summary

A specific hemorheologic treatment might reduce urinary protein excretion and the decline in kidney function in diabetic patients with overt clinical nephropathy. Twenty-one insulin dependent (type I) diabetic patients were randomized and assigned to a treatment with conventional antihypertensive therapy (protocol I) or with pentoxifylline (Trental 400®) (protocol II). A marked improvement of blood rheology pattern, together with a reduction of urinary albumin excretion rate and total urinary protein excretion rate, was demonstrated throughout a 1-year follow-up study with pentoxifylline. Furthermore a decrease of systolic and diastolic blood pressure levels was found during the treatment. The modification of these parameters was followed by a significant increase of creatinine clearance in each of the patients studied. The results obtained during pentoxifylline therapy were comparable to those obtained in patients treated with conventional antihypertensive drugs. Pentoxifylline may therefore be used in the treatment of advanced nephropathy in diabetic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aprile C., Saponaro R., Solerte S. B.: Determination of glomerular filtration rate by Gates' method—J. nucl. Med.27, 1644, 1986.

    PubMed  CAS  Google Scholar 

  2. Armitage P.: Statistical methods in medical research. Blackwell Sci. Publ., Oxford-Edinburgh, 1971.

    Google Scholar 

  3. Bradford M. M.: A rapid and sensitive method for the quantitation of microgram quantitaties of protein utilizing the principle of protein dye binding—Analyt. Biochem.72, 248, 1976.

    Article  PubMed  CAS  Google Scholar 

  4. Cordaro C., Carandente O.: Esperienze pratiche sulla metodica di filtrazione eritrocitaria— La Ricerca Clin. Lab.10 (Suppl. 1), 113, 1980.

    Google Scholar 

  5. Di Perri T., Guerrini M.: Placebo controlled double blind study with pentoxifylline of walking performance in patients with intermittent claudication—Angiology30, 40, 1983.

    Google Scholar 

  6. Ferrari E., Fioravanti M., Patti A. L., Viola C., Solerte S. B.: Effects of a long-term treatment (4-years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients—Pharmatherapeutica (in press).

  7. Gates G. F.: Glomerular filtration rate: estimation from fractional renal accumulation of 99 mTc-DTPA (stannous)—Amer J. Radiol.138, 565, 1982.

    CAS  Google Scholar 

  8. Guerrini M., Pecchi S., Rossi A., Cappelli R., Pieragalli D., Acciavatti A.: Effect of pentoxifylline on blood hyperviscosity and peripheral haemodynamics in patients with peripheral obliterating arterial disease—Pharmatherapeutica3 (Suppl. 1), 52, 1983.

    Google Scholar 

  9. Laurell C.: Quantitative estimation of protein by electrophoresis in agarose gel containing antibodies—Analyt. Biochem.15, 45, 1966.

    Article  PubMed  CAS  Google Scholar 

  10. Letcher R. L., Chien S., Pickering T. G., Sealey J. E., Laragh J. H.: Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects—Amer. J. Med.70, 1195, 1981.

    Article  PubMed  CAS  Google Scholar 

  11. Mancini G., Carbonara A. O., Heremans J. F.: Immunochemical quantitation of antigens by single radial immunodiffusion—Immunochemistry2, 235, 1965.

    Article  PubMed  CAS  Google Scholar 

  12. Mogensen C. E.: Progression of nephropathy in long-term diabetics with proteinuria and effect of initial antihypertensive treatment—Scand. J. clin. Lab. Invest.36, 383, 1976.

    PubMed  CAS  Google Scholar 

  13. Mogensen C. E., Christensen C. K., Vittinghus E.: The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy—Diabetes32 (Suppl. 2), 64, 1983.

    PubMed  Google Scholar 

  14. Muggeo M., Calabrò A., Businaro V., Patussi L., Volpe A., Signorini G. P., Crepaldi G.: Blood clotting, fibrinolytic and haemorheological parameters in ischaemic vascular disease: the effects of pentoxifylline in the treatment of acute cerebral vascular disease—Pharmatherapeutica3 (Suppl. 1), 74, 1983.

    Google Scholar 

  15. Müller R., Lehrach F.: Haemorheological role of platelet aggregation and hypercoagulability in microcirculation: therapeutical approach with pentoxifylline—Pharmatherapeutica2, 372, 1980.

    PubMed  Google Scholar 

  16. Parving H-H., Andersen A. R., Smidt U. M., Svendsen P.Aa.: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy—Lanceti, 1175, 1983.

    Article  Google Scholar 

  17. Pozza G., Cordaro C., Carandente O., Margonato A.: Studio sul rapporto tra filtrazione eritrocitaria ed altri fattori di rischio nell'angiopatia diabetica—La Ricerca Clin. Lab.11 (Suppl. 1), 317, 1981.

    Google Scholar 

  18. Satewachin I. I., Ilijn V. N., Schestaka V. A., Alexandrova N. P., Rodionov S. V., Danilova L. M., Ilijn S. G.: The use of pentoxifylline in a combined regimen for the prevention of rethrombosis in major blood vessels—Pharmatherapeutica2, 109, 1978.

    Google Scholar 

  19. Simpson L. O.: A hypothesis proposing increased blood viscosity as a cause of proteinuria and increased vascular permeability—Nephron31, 89, 1982.

    Article  PubMed  CAS  Google Scholar 

  20. Simpson L. O.: Intrinsic stiffening of red blood cells as the fundamental cause of diabetic nephropathy and microangiopathy—Nephron39, 344, 1985.

    PubMed  CAS  Google Scholar 

  21. Solerte S. B., Adamo S., Viola C., Carnevale Schianca G. P., Crippa A., Cozzi A., Ferrari E.: Modificazioni emoreologiche e proteinuria nel diabete mellito complicato—G. ital. Diabetol.4, 245, 1984.

    Google Scholar 

  22. Solerte S. B., Adamo S., Viola C., Zambianchi E., Ferrari E.: Pentossifillina ed arteriosa nel diabete mellito: risultati a lungo termine in gruppi randomizzati. In:Pozza G., Carandente O. (Eds): Emoreologia in laboratorio ed in clinica—La Ricerca Clin. Lab.15, (Suppl. 1), 515, 1985.

    Google Scholar 

  23. Solerte S. B., Aprile C., Adamo S., Saponaro R., Carena M., Ferrari E. Blood viscosity and glomerular filtration rate in diabetes mellitus—Clin. Hemorheol.5, 693, 1985.

    Google Scholar 

  24. Solerte S. B., Aprile C., Fioravanti M., Viola C., Bacchella L., Zanoletti M., Patti A. L., Ferrari E.: Decreased renal plasma flow, blood hyperviscosity and plasma protein changes in type 1 (insulin-dependent) diabetics with overt nephropathy—Transplant. Proc.18, 1641, 1986.

    Google Scholar 

  25. Solerte S. B., Carnevale Schianca G. P., Adamo S., Viola C., Baldi S., Sgarro V., Ferrari E.: Diabetic microangiopathy: preventive therapeutical approach with pentoxifylline—Clin. Hemorheol.3, 290, 1983.

    Google Scholar 

  26. Solerte S. B., Carnevale Schianca G. P., Canepari C., Baldi F., Adamo S., Viola C., Ferrari E.: Erythrocyte deformability and its correlation with plasma protein changes and glycosylated haemoglobin in complicated diabetes mellitus—Diabetologia23, 304, 1982; abstract # 73.

    Google Scholar 

  27. Solerte S. B., Carnevale Schianca G. P., Viola C., Adamo S., Cozzi A., Crippa A., Ferrari E.: Pathogenetic mechanism of haemorheological factors in development and progression of diabetic nephropathy—Clin. Hemorheol.3, 327, 1983.

    Google Scholar 

  28. Solerte S. B., Ferrari E.: Diabetic retinal vascular complications and erythrocyte filtrability: results of a 2-year follow-up study with pentoxifylline—Pharmatherapeutica4, 341, 1985.

    PubMed  CAS  Google Scholar 

  29. Solerte S. B., Fioravanti M., Aprile C., Patti A. L., Viola C., Saponaro R., De Rocco O., Schifino N., Zanoletti M., Bacchella L., Ferrari E.: Iperviscosità ematica e iperfiltrazione glomerulare in pazienti con diabete mellito insulino-dipendente di recente diagnosi—G. ital. Diabetol.6, 459, 1986.

    Google Scholar 

  30. Solerte S. B., Fioravanti M., Bozzetti A., Schifino N., Patti A. L., Fedele P., Viola C., Ferrari E.: Pentoxifylline, albumin excretion rate and proteinuria in type 1 and type 2 diabetic patients with microproteinuria. Results of a short-term randomized study—Acta diabetol. lat.23, 171, 1986.

    Article  PubMed  CAS  Google Scholar 

  31. Solerte S. B., Fioravanti M., Patti A. L., Zanoletti M. G., Schifino N., Mancin D., Zambianchi E., Aprile C., Ferrari E.: Variazioni dei livelli di fattore von Willebrand antigene e della fibronectina plasmatica in pazienti diabetici con iperfiltrazione glomerulare —G. ital. Diabetol. (in press).

  32. Solerte S. B., Piovella F., Viola C., Carnevale Schianca G. P., Gamba G., Fioravanti M., Ferrari E.: Plasma fibronectin, von Willebrand factor antigen, and blood rheology. Association with diabetic microvascular disease—Acta diabetol. lat.22, 239, 1985.

    Article  PubMed  CAS  Google Scholar 

  33. Solerte S. B., Viola C., Adamo S., Carnevale Schianca G. P., Dalzano M., Ferrari E.: Proteinuria, microalbuminuria ed iperviscosità nel diabete mellito insulino-dipendente (tipo I). In:Pozza G., Carandente O. (Eds): Emoreologia in laboratorio ed in clinica—La Ricerca Clin. Lab.15 (Suppl. 1), 383, 1985.

    Google Scholar 

  34. Solerte S. B., Viola C., Adamo S., Carnevale Schianca G. P., Dalzano M., Ferrari E.: A xanthine derivative, pentoxifylline, in the treatment of diabetic nephropathy—Diabetes Res. (Suppl. 1), 526, 1985.

    Google Scholar 

  35. Solerte S. B., Viola C., Adamo S., Dalzano M., Carnevale Schianca G. P., Ferrari E.: Ipertensione arteriosa, iperviscosità e proteinuria nel diabete mellito insulino-dipendente di lunga durata. In:Pozza G., Carandente O. (Eds): Emoreologia in laboratorio ed in clinical— La Ricerca Clin. Lab.15 (Suppl. 1), 389, 1985.

    Google Scholar 

  36. Solerte S. B., Viola C., Bozzetti A., Adamo S., Di Santi M., Fioravanti M., Ferrari E.: Ipertensione arteriosa, iperviscosità ematica e complicanze microangiopatiche nel diabete mellito non insulino dipendente (tipo 2)—G. ital. Diabetol.5, 373, 1985.

    Google Scholar 

  37. Strano A., Davi G., Novo S., Avellone G., Pinto A.: Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders—Pharmatherapeutica3 (Suppl. 1), 117, 1983.

    Google Scholar 

  38. Viberti G. C., Keen H.: The patterns of proteinuria in diabetes mellitus. Relevance to pathogenesis and prevention of diabetic nephropathy—Diabetes33, 686, 1984.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Solerte, S.B., Fioravanti, M., Patti, A.L. et al. Pentoxifylline, total urinary protein excretion rate and arterial blood pressure in long-term insulin-dependent diabetic patients with overt nephropathy. Acta diabet. lat 24, 229–239 (1987). https://doi.org/10.1007/BF02732042

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02732042

Key-words

Navigation